chartexchange

Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1

GlobeNewswire Inc. | Oct 11, 2026 11:42 AM EDT

- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1

Read original article